GeneDx Holdings Debt-to-Equity Ratio Growth & History (WGS)

GeneDx Holdings's debt-to-equity ratio was 0.37 for fiscal 2025.

View full GeneDx Holdings company overview

GeneDx Holdings annual debt-to-equity ratio history

GeneDx Holdings annual debt-to-equity ratio

Fiscal yearPeriod endedDebt-to-equity ratioChangeGrowth
20252025-12-310.37−0.11−23.28%
20242024-12-310.48−0.05−8.88%
20232023-12-310.530.22+72.77%
20222022-12-310.300.22+259.74%
20212021-12-310.08

GeneDx Holdings debt-to-equity ratio trends

Between the periods ended 2021-12-31 and 2025-12-31, GeneDx Holdings's debt-to-equity ratio increased from 0.08 to 0.37, a change of 0.28. The latest reported quarter, Q2 2026, shows 0.40.

About the metric

What the debt-to-equity ratio means

The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.

Calculation and source

How debt-to-equity is calculated

TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review GeneDx Holdings source filings ↗

Community posts

It’s quiet here.

No posts about WGS yet. Start the conversation.

Write the first post